The study of investigating the genetic profiles of Exceptional Response in cancer therapies.

The study of investigating the genetic profiles of Exceptional Response in cancer therapies. - The study of investigating the genetic profiles of Exceptional Response in cancer therapies.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000016643

Enrollment

Registered

2015-02-26

Start date

2015-01-06

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer patient who received therapies.

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Cancer patient who will receive therapies 2)Samples meeting one of the followings: 1.Surplus sample stored in the NCC biobank 2.Surplus sample diagnostic biopsy 3.Surgical surplus tumor sample

Exclusion criteria

Exclusion criteria: Judged ineligible by the clinical investigators

Design outcomes

Primary

Measure	Time frame
Analysis of somatic gene mutation, gene expression of tumor tissue	—

Countries

Japan

Contacts

Public ContactTakafumi Koyama

National Cancer Center Hospital Department of Experimental Therapeutics

takoyama@ncc.go.jp03-3542-2511

Outcome results